Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-14

Clinical Trial Update: The Use of Melatonin for Delirium Prevention in Medically Hospitalized Patients [Phase 2, Phase 3]

View source ↗

Summary

This update describes an ongoing Phase 2/Phase 3 clinical trial evaluating melatonin for delirium prevention in medically hospitalized patients. The study is sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Sultan Qaboos University | Conditions: Delirium | Phase 2, Phase 3 | Status: RECRUITING